Browse Studies — Arctuva

Phase 2

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good blood sugar contro…

Type II Diabetes Mellitus

Estimated

~$10 – $8,750

Corxel PharmaceuticalsNCT07340320

Observational

Prompting a Switch From Refined Grains to Whole Grains in an Online Grocery Store Using Marketing Nudges and Financial Incentives

Only 2% of Americans meet the recommended levels of whole grain consumption, despite its association with reduced risk of type 2 diabetes. This study aims to a…

Type 2 DiabetesType II Diabetes MellitusType II Diabetes+6 more

Estimated

~$10 – $6,250

University of PennsylvaniaNCT07167004

Phase 2

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of GL0034 Among Type II Diabetes Mellitus Subjects Who Are Obese or Overweight With Weight-related Comorbidities

This is a phase II, randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of GL0034 among type II diabetes mellitus subj…

Type II Diabetes Mellitus

Estimated

~$10 – $8,750

Sun Pharmaceutical Industries LimitedNCT07282743

Phase 1

A Phase 1 Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of GL0034

This is an open-label, single-dose, Phase 1 clinical study designed to evaluate the effect of renal impairment on the pharmacokinetics (PK) of GL0034, a long-a…

Type II Diabetes Mellitus

Estimated

~$10 – $8,750

Sun Pharmaceutical Industries LimitedNCT07385547